Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis
- 28 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 103 (5) , 945-954
Abstract
The immune mechanisms underlying the pathogenesis of tuberculosis (TB) need better understanding to improve TB management, as the disease still causes more than 1.5 million deaths annually. This study tested the hypothesis that a modulation of the proportions or activation status of APC during Mycobacterium tuberculosis infection may impact on the course of the disease. Proportions of circulating APC subsets and the expression of stimulatory (CD86), inhibitory (ILT-3, ILT-4, ILT-7), or apoptosis-inducing (PDL-1, PDL-2) molecules were analyzed in 2 independent cohorts, on blood monocytes and dendritic cell (DC) subsets from patients with active or latent TB infection (aTB /LTBI) and from uninfected subjects. Higher proportions of classical CD14+CD16− and intermediate CD14+CD16+ monocytes, and lower proportions of plasmacytoid DC (pDC) and type 2 myeloid DC were observed in the blood from untreated patients with aTB compared with those with LTBI and with healthy subjects, with an early normalization of the proportions of pDC during treatment. In addition, monocytes from M. tuberculosis-infected subjects expressed higher levels of ILT-3, ILT-4, and PDL-1 compared with healthy controls, these differences being more important for patients with aTB than for those with LTBI. These results confirm the hypothesis of a modulation of the proportions and activation status of APC during M. tuberculosis infection and suggest that these cells could play a role in driving the course of M. tuberculosis infection.Keywords
This publication has 24 references indexed in Scilit:
- Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stagesPLOS ONE, 2017
- Impairments of Antigen-Presenting Cells in Pulmonary TuberculosisJournal of Immunology Research, 2015
- Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis–Specific Interferon γ–Producing T Cells From Apoptosis in Patients With Pulmonary TuberculosisThe Journal of Infectious Diseases, 2013
- Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infectionTuberculosis, 2011
- Nomenclature of monocytes and dendritic cells in bloodBlood, 2010
- Signaling and ligand interaction of ILT7: receptor‐mediated regulatory mechanisms for plasmacytoid dendritic cellsImmunological Reviews, 2010
- Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatmentMicrobes and Infection, 2006
- Circulating dendritic cells and interferon-α production in patients with tuberculosis: correlation with clinical outcome and treatment responseClinical and Experimental Immunology, 2005
- High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology, 2003
- Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4Nature Immunology, 2002